NatureWise Biotech & Medicals Corporation (TPEX:4732)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
20.90
+1.15 (5.82%)
At close: Feb 11, 2026
Market Cap982.35M -13.9%
Revenue (ttm)180.29M -19.7%
Net Income-37.01M
EPS-0.75
Shares Out47.00M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume47,562
Average Volume13,823
Open19.95
Previous Close19.75
Day's Range19.25 - 20.90
52-Week Range17.40 - 27.85
Beta0.69
RSI54.14
Earnings DateNov 14, 2025

About TPEX:4732

NatureWise Biotech & Medicals Corporation engages in the research and development of Western medicine, Chinese medicine, and biotechnology in Taiwan. It offers LipoCol Forte, a capsule for hypercholesterolemia and hypertriglyceridemia; and green propolis and red yeast rice products. The company was founded in 1990 and is headquartered in Taipei, Taiwan. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1990
Employees 31
Stock Exchange Taipei Exchange
Ticker Symbol 4732
Full Company Profile

Financial Performance

In 2024, TPEX:4732's revenue was 224.32 million, an increase of 40.08% compared to the previous year's 160.14 million. Earnings were 897,000, a decrease of -91.14%.

Financial Statements